Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioMarin Pharmaceutical Inc. - Common Stock
(NQ:
BMRN
)
53.89
-1.14 (-2.07%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,109,389
Open
55.22
Bid (Size)
53.70 (100)
Ask (Size)
55.62 (100)
Prev. Close
55.03
Today's Range
53.88 - 55.34
52wk Range
50.76 - 73.51
Shares Outstanding
183,352,255
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
2 Reasons to Like BMRN and 1 to Stay Skeptical
November 24, 2025
BioMarin Pharmaceutical currently trades at $55.56 per share and has shown little upside over the past six months, posting a small loss of 4.4%. The stock also fell short of the S&P 500’s 11.5% gain...
Via
StockStory
Topics
Stocks
Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks
November 23, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with BioMarin...
Via
StockStory
Topics
Artificial Intelligence
Performance
YTD
-19.0%
-19.0%
1 Month
+2.0%
+2.0%
3 Month
-8.8%
-8.8%
6 Month
-5.1%
-5.1%
1 Year
-17.1%
-17.1%
More News
Read More
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know
November 21, 2025
Via
StockStory
Topics
Economy
Government
World Trade
BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?
November 20, 2025
Via
StockStory
Topics
Stocks
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.
↗
November 20, 2025
Via
The Motley Fool
1 Safe-and-Steady Stock on Our Watchlist and 2 We Question
November 12, 2025
Via
StockStory
Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
November 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Stocks
The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market
November 14, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
3 Cash-Producing Stocks with Promising Prospects
November 09, 2025
Via
StockStory
This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
↗
November 06, 2025
Via
Benzinga
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case
↗
November 05, 2025
Via
Chartmill
The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call
November 03, 2025
Via
StockStory
Topics
Earnings
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
↗
October 28, 2025
Via
The Motley Fool
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
October 28, 2025
Via
StockStory
Topics
Earnings
Economy
Government
Biomarin Pharmaceutical Analysts Cut Their Forecasts After Downbeat Earnings
↗
October 28, 2025
Via
Benzinga
BMRN Q3 Deep Dive: Product Expansion and Portfolio Shifts Define Outlook
October 28, 2025
Via
StockStory
BioMarin (BMRN) Q3 2025 Earnings Call Transcript
↗
October 27, 2025
Via
The Motley Fool
Topics
Earnings
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Reports Mixed Q3 2025 Results with Revenue Growth but Earnings Miss
↗
October 27, 2025
Via
Chartmill
Topics
Earnings
BioMarin Pharmaceutical (NASDAQ:BMRN) Posts Q3 Sales In Line With Estimates
October 27, 2025
Via
StockStory
Earnings Scheduled For October 27, 2025
↗
October 27, 2025
Via
Benzinga
BioMarin Pharmaceutical (BMRN) Reports Q3: Everything You Need To Know Ahead Of Earnings
October 25, 2025
Via
StockStory
Topics
Artificial Intelligence
What to Expect from Biomarin Pharmaceutical's Earnings
↗
October 24, 2025
Via
Benzinga
3 of Wall Street’s Favorite Stocks to Target This Week
October 24, 2025
Via
StockStory
1 Healthcare Stock Worth Investigating and 2 We Question
October 17, 2025
Via
StockStory
Topics
Stocks
1 Mid-Cap Stock to Research Further and 2 That Underwhelm
October 15, 2025
Via
StockStory
Frequently Asked Questions
Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 53.89
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 12/02/25 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 9.88B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.